Today’s AI Top Pick: CSV

7/24/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Low Float Bullish Consensus Deep RotationCSVBUY NOW7.8 / 107/24/2026

Carriage Services (CSV) is the cleanest 'fundamentals + tape confirmation' setup in the pool today. On the fundamentals side, it clears the screen with real profitability, not the biotech-hope profile most of these names carry: PE 13.65, fwdPe 10.04, ROE 17.76%, operMargin 23.47%, profitMargin 10.45%, analyst recom 1.2 (strong buy), and 58.9% target upside. Institutional ownership 80.13% and the just-declared dividend confirm this is real cash-flow business, not a lottery ticket — fundamental_score 6.25 is the best among names that also have a bullish near-term tape. The multi-timeframe forecast is uniformly positive without the 'top of the range' problem that plagues HURN. Every single horizon calls for upside: 1h fc (+11.5% / +14.6% / +19.2%), 4h (+11.6% / +14.0% / +15.4%), and 1d (+4.2% / +15.4% / +13.9%). Bullish_prob = 1.0 and near_term_bullish = 1.0 — the highest tier. Critically, price is NOT extended: 4h position 40.87%, 1d position 40.58%, 1wk sitting at 1.76% of its 21-bar range with a -26% weekly drawdown. That is exactly the 'middle-to-lower range with room to run' profile the mandate asks for. Contrast this to the other top scorers: DCBO (score 15.5) has better fundamentals on paper (PEG 0.47, ROE 132.85) but its short-horizon forecasts are actually negative (1h fc_short -0.07%, 4h -3.81%, 1d -6.5%) and near_term_bullish is only 0.2 — the tape is not confirming today. HURN (score 14.5) has strong forecasts but is at 89.72% of its 4h range and 66.54% on 1d after an 18% bounce — you would be chasing. TASK has excellent forecasts but recom 2.86 (weak) and 1wk still negative. CSV threads the needle: real fundamentals, all-timeframe bullish forecasts, and an un-extended entry price. The one landmine to acknowledge is a July 21 StockStory 'Reasons to Sell CSV' piece — but this is a syndicated opinion column, not a guidance cut, lawsuit, or dilution event, and it's counterbalanced by the July 16 dividend declaration and a July 7 Seeking Alpha bull piece ('Buried But Not Forgotten'). No material negative catalyst undercuts the thesis, so today's entry is justified rather than waiting for a deeper pullback that may not come.

Entry zone

$37.20–$37.90 (current $37.77, scale in on any intraday dip toward the 1d low near $36.20)

Stop loss

$34.90 (below the 1d 21-bar low; ~7.6% risk, aligns with -4.16% drawdown floor breaking)

First target

$42.50 (+12.5%, aligns with 1d fc_mid +15.37% and 1h fc_long +19.22%)

Longer target

$48–$52 (swing target on analyst-consensus 58.9% upside, ~$60 full target)

Risks

Weekly tape still bruised: 1wk recent_21bar -12.87% with dd_from_high -26.13% — a broader downtrend hasn't been fully broken
Debt/equity 2.05 is elevated for a small-cap consumer-cyclical; rate volatility or refi risk could pressure multiple
Sales growth is anemic at +1.16% YoY — thesis leans on margin/multiple expansion, not top-line
StockStory 'Sell' article from 7/21 could weigh on retail sentiment even if not substantive
Market cap $599M with sub-20M float means a 5–8% adverse gap is realistic on any negative print

Honorable mentions

HURNBest pure fundamentals (recom 1.0, ROE 23.27, fwdPe 10.69, 44%-undervalued headline) with strong 1h/4h/1d forecasts (+7% / +16% / +26% mid), but 4h position at 89.72% of range means you're chasing an 18% bounce — better as a pullback buy to $102–105 than a market-order today.

TPBRSI 32.66 (oversold), recom 1.0, operMargin 19.63%, and strong 4h/1d forecasts (+26% / +31% mid) with position at 0% of 1d range — deep-value bounce setup, but fwdPe 35.14 and negative 1wk forecast (-30%) cap the upside vs. CSV.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	CSV	BUY NOW	7.8	All-timeframe bullish forecast with fundamental_score 6.25, mid-range entry, and no landmine headlines.
2	HURN	BUY PULLBACK	7.4	Best fundamentals in pool but 4h position 89.7% — wait for retest of $102–105.
3	DCBO	BUY PULLBACK	6.9	Elite fundamentals (PEG 0.47, ROE 132.85) and $70M buyback, but near-term forecasts negative (1h -0.07%, 4h -3.81%).
4	TASK	BUY NOW	6.8	Cheap (fwdPe 3.48) with huge 4h forecast (+94.99% long), but recom 2.86 dilutes conviction.
5	TPB	BUY NOW	6.4	Oversold (RSI 32.66) mean-reversion with recom 1.0 and strong mid-horizon forecasts.
6	UI	WAIT	5.6	Zacks upgrade to Strong Buy but 1wk forecast -50% long and position at 0% of 1h range — knife-catching risk.
7	EVGN	BUY PULLBACK	5.3	Positive PCSK9 catalyst + 4h/1d position 91%/62% — extended after 26–35% bounce.
8	BESS	WAIT	5.1	Massive forecasts (+94% 4h long) but at 0% of 1d range with -39.8% drawdown — falling knife.
9	GLMD	BUY PULLBACK	5.0	Positive patent + LNP catalyst but 1h already at 100% of range, chase risk.
10	MBRX	WAIT	4.7	Huge weekly forecast (+966% mid) but 6/30 trial data miss caused -25% drop; credibility hit.
11	DRMA	BUY PULLBACK	4.6	1d fc_long +162% but 1h fc's all negative — no near-term confirmation.
12	BCDA	WAIT	4.5	Sales YoY -100% is a red flag despite +218% weekly forecast.
13	GRCE	WAIT	4.4	Debt-free with 155% target upside but 1wk dd -54% and no catalyst in news.
14	ROOT	WAIT	4.3	Positive analyst upgrades but 1h/4h forecasts negative and epsNextY -17.79%.
15	PRSO	AVOID	4.2	7/2 $25M ATM equity line = ongoing dilution overhang despite big forecasts.
16	SHOE	BUY PULLBACK	4.1	PE 10.57 and 21% short float squeeze potential but recom 2.33 and sales -4.4%.
17	CALC	WAIT	4.0	$49M PIPE dilution recent, though FDA green light on Auxora is a positive.
18	LTRN	WAIT	3.9	USPTO patent catalyst but 4h dd -31% and 1h forecasts flat/negative.
19	QNTM	AVOID	3.8	ROE -984, -87% year, RSI 30.96; too broken despite huge weekly forecast.
20	TTEC	AVOID	3.7	Debt/equity 11.65 is a solvency-level red flag, ROE -115.95.
21	AMR	WAIT	3.6	Recom 2.83, UBS Neutral initiation, and only 24.8% target upside — thesis thin.
22	JACK	AVOID	3.5	40% short float and analyst target cuts; StockStory 'Reasons to Avoid' this week.
23	NXTC	AVOID	3.4	Reverse-merging into Avere — legacy holders get CVR only, not clean equity thesis.
24	LUCY	AVOID	3.3	Recent warrant exercise dilution ($3M), operMargin -300%, near_term_bullish 0.
25	INTZ	WAIT	3.2	1h fc's all negative despite investor day hype; -34% YTD.
26	HSCS	AVOID	3.0	PS 803, operMargin -89939%; 1h forecasts all deeply negative.
27	WW	AVOID	2.9	Only 1d data, sales -9.61%, bullish_prob null — post-restructuring uncertainty.
28	TOYO	AVOID	2.8	Expected_return_pct -11.16% — the only negative expected return in the pool.
29	CRE	AVOID	2.7	perfYear -94.98%, bullish_prob null, 1h/1d forecasts negative.
30	IPWR	AVOID	2.5	7/10 $75M mixed-shelf prospectus = imminent dilution overhang; PS 2238.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord